Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Nov;7(9):407-9.

Long term efficacy of propafenone for prevention of atrial fibrillation

A E Kyles  1 , C J Murdock, J A Yeung-Lai-Wah, S Vorderbrugge, C R Kerr
Affiliations
  • PMID: 1756420

Long term efficacy of propafenone for prevention of atrial fibrillation

A E Kyles et al. Can J Cardiol. 1991 Nov.

Abstract

Objective: Propafenone, a class IC antiarrhythmic drug, has been successful in the treatment of ventricular and supraventricular arrhythmias. This study retrospectively evaluated the efficacy of propafenone in the prevention of recurrent atrial fibrillation.

Design: Propafenone was given to 81 patients (49 males and 32 females, mean age 61 +/- 16 years) with recurrent atrial fibrillation. The mean dose of propafenone was 701 +/- 235 mg. Patients were monitored for recurrent arrhythmias.

Main results: Long term follow-up over 30 +/- 1.7 months showed 31 patients (38%) remained on propafenone with complete or partial control of atrial fibrillation. The drug was stopped in 35 due to inefficacy, in 12 due to adverse effects, and in three due to desire for ablation therapy.

Conclusion: Propafenone may be effective in some patients for long term prevention of atrial fibrillation, although efficacy may decrease over time.

PubMed Disclaimer

Publication types

LinkOut - more resources